1 World Health Organization.Acute respiratory syndrome in Hongkong special administrative regionof China/Vietnam[S]. 2003 2 Thomas G, Ksiazek K. A novel coronavirus associated with severe acute respiratory syndrome[J]. N Engl J Med, 2003;348 (20): 1953-66 3 World Health Organization.Cumulative number of reported probable case of Severe Acute Respiratory Syndrome (SARS) [S]. 2003 4 Zhaori G.Antiviral treatment of SARS: Can we draw any conclusions[J]. CMAJ, 2003;169(11): 1165-6 5 谭敦宪, 霍玉书, 杜冠华, 张均田.Melatonin 及其衍生物作为急性严重呼吸系统综合征急救用药的理论基础和临床应用的可行性[J]. 中国药理学通报, 2003; 19(7): 721-3 6 传染性非典型肺炎诊断标准(试行) [S]. 中华人民共和国卫生部, 2003 7 WHO 国际药品不良反应监察计算机软件说明[CP]. 国家药品不良反应监测中心, 1993 8 Holme KV.SARS-associated coronavirus[J]. N Engl J Med, 2003; 348(20): 1948-51 9 Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China [J]. JMed Microbiol, 2003; 52(8): 715-20 10 Ooth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area [J]. JAMA, 2003;289(21): 2801-9 11 王睿, 周筱青, 董军, 魏荣, 曹秀堂, 周亚春, 等.小汤山医院680 例SARS 患者药物利用分析[J]. 中国循证医学杂志, 2004; 4(7): 468-74 |